Psychedelic-assisted therapy is the subject of renewed focus. It involves using psilocybin—a substance found in psychoactive ...

Louisiana is one step away from creating a state-backed psychedelic-assisted therapy initiative focused on clinical research ...

A bipartisan coalition of 32 members of Congress is urging federal health officials to expedite ongoing reviews of ...

A new FDA regulatory pathway could accelerate approval of psychedelic therapies for resistant depression and PTSD, and ...

President Trump issued an executive order to fast-track psychedelic therapies like ibogaine to treat PTSD and other mental ...

Louisiana lawmakers have passed a bill to create a psychedelic-assisted therapy pilot program, using opioid settlement ...

Federal directives deploy priority review vouchers, earlier DEA rescheduling, and ARPA-H matching funds to compress ...

Utah authorizes a state-funded clinical trial studying psychedelic-assisted therapy for veterans with treatment-resistant PTSD, marking a cautious, evidence-first approach to psychedelic research.

The legislation would broaden the psychedelic-assisted therapy pilot program beyond veterans, first responders and healthcare ...

The study found that the bigger the psychedelic trip, the bigger the changes. None of the subjects reported a trip with the placebo dose, but all but one reported “significant alterations in their ...